BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
BioInvent International Total Liabilities (Quarterly): 9.011M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.011M |
| December 31, 2023 | 8.985M |
| September 30, 2023 | 7.034M |
| June 30, 2023 | 11.27M |
| March 31, 2023 | 8.945M |
| December 31, 2022 | 10.18M |
| September 30, 2022 | 6.361M |
| June 30, 2022 | 8.746M |
| March 31, 2022 | 8.820M |
| December 31, 2021 | 8.879M |
| September 30, 2021 | 8.494M |
| June 30, 2021 | 9.402M |
| March 31, 2021 | 7.031M |
| December 31, 2020 | 7.222M |
| September 30, 2020 | 5.548M |
| June 30, 2020 | 6.157M |
| March 31, 2020 | 5.773M |
| December 31, 2019 | 6.065M |
| September 30, 2019 | 6.475M |
| June 30, 2019 | 7.479M |
| March 31, 2019 | 5.529M |
| December 31, 2018 | 3.650M |
| September 30, 2018 | 2.751M |
| June 30, 2018 | 4.654M |
| March 31, 2018 | 4.983M |
| Date | Value |
|---|---|
| December 31, 2017 | 4.870M |
| September 30, 2017 | 3.763M |
| June 30, 2017 | 4.21M |
| March 31, 2017 | 3.392M |
| December 31, 2016 | 5.058M |
| September 30, 2016 | 3.863M |
| June 30, 2016 | 3.587M |
| March 31, 2016 | 3.486M |
| December 31, 2015 | 2.972M |
| September 30, 2015 | 2.232M |
| June 30, 2015 | 2.216M |
| March 31, 2015 | 2.173M |
| December 31, 2014 | 2.797M |
| September 30, 2014 | 2.758M |
| June 30, 2014 | 4.170M |
| March 31, 2014 | 3.713M |
| December 31, 2013 | 5.058M |
| September 30, 2013 | 4.210M |
| June 30, 2013 | 5.013M |
| March 31, 2013 | 8.598M |
| December 31, 2012 | 10.60M |
| September 30, 2012 | 17.13M |
| June 30, 2012 | 15.14M |
| March 31, 2012 | 9.043M |
| December 31, 2011 | 9.840M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.548M
Minimum
Sep 2020
11.27M
Maximum
Jun 2023
7.894M
Average
7.986M
Median
Total Liabilities (Quarterly) Benchmarks
| Abliva AB | 0.9668M |
| Karolinska Development AB | 1.233M |
| Calliditas Therapeutics AB | 147.20M |
| Oncopeptides AB | 14.80M |
| Olink Holding AB | 81.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 124.72M |
| Shareholders Equity (Quarterly) | 115.71M |
| Current Ratio | 13.45 |